West Virginia · 2026 Regular Session
The purpose of this bill is to establish a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the Administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.
Vetoed by Governor 4/1/2026 - House Journal (2026-03-14)